A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants

Condition:   Healthy Interventions:   Drug: Selpercatinib;   Drug: Moxifloxacin;   Drug: Placebo Sponsors:   Eli Lilly and Company;   Loxo Oncology, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials